Clinical Trial to Determine the Efficacy and Safety of Insulin Eye Drops in Dry Eye in Patients with Topical Hypotensors
Eligible age
18+ yrs
Accepts
All genders
Locations
0 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The goal of this clinical trial is to evaluate the preliminary efficacy of the use of insulin eye drops in the control of dry eye disease in patients with topical hypotensors, compared to placebo (artificial tears). The main question aims to answer whether glaucoma patients treated with topical hypotensors could benefit from the use of insulin eye drops for the treatment of dry eye. Participants will be assigned to one of the two treatment arms and will be required to attend four follow-up visits (baseline, 1, 3, and 6 months).
Sponsor: Barbara Burgos Blasco
You may qualify if…
- ✓ Patients who provide written informed consent and who are able and willing to comply with all scheduled study visits and procedures.
- ✓ Patients ≥ 18 years at the screening visit.
- ✓ Ocular hypertension or glaucoma controlled with hypotensive treatment
- ✓ Diagnosis of dry eye
You may not qualify if…
- ✕ Uncontrolled glaucoma with expected changes in antihypertensive treatment in the next 6 months
- ✕ Changes in topical glaucoma treatment in the last 3 months
- ✕ Severe dry eye requiring immediate treatment
- ✕ Previous eye surgery, except cataract surgery more than 12 months ago
- ✕ Laser procedures less than 6 months ago
- ✕ Other concomitant ocular pathology: scarring disease of the ocular surface, uveitis, infection in the last 90 days, trauma in the last 90 days
- ✕ Eyelid disorders
- ✕ Use of contact lenses
Source: ClinicalTrials.gov · NCT06017362 · last updated 2024-10-22